| | 7542-37-2 Basic information More.. |
| Product Name: | paromomycin | | Synonyms: | PAROMOMYCIN,O-2-AMINO-2-DEOXY-ALPHA-D-GLUCOPYRANOSYL-(1-4)-O-[O-2,6-DIAMINO-2,6-DIDEOXY--L-IODOPYRANOSYL-(1-3)--D-RIBOFURANOSYL-(1-5)]-2-DEOXY-D-STREPTAMINE;Paromomycinsulfat;Aminosidin;Aminosidine I;Amminosidin;Antibiotic 2230D;Antibiotic 503-3;Antibiotic SF 767B | | CAS: | 7542-37-2 | | MF: | C23H45N5O14 | | MW: | 615.63 | | EINECS: | 231-423-0 | | Mol File: | 7542-37-2.mol |  |
Use
Paromomycin, an aminoglycoside antibiotic was introduced into
medicine in 1959 for the treatment of protozoal, helminthic and bacterial infections.
It has been associated, particularly when used by parenteral route, with severe
adverse effects including renal damage, neuromuscular blockage and ototoxicity,
possibly leading to deafness in some patients. This route of administration is now
considered obsolete. However, parenteral dosage forms of paromomycin may still
remain available in certain countries.
- paromomycin
-
- US $1.00 / g
- 2019-12-26
- CAS:7542-37-2
- Min. Order: 1g
- Purity: ≥98%
- Supply Ability: g/kg/Ton
|
|
7542-37-2
Recommend Suppliers |
|